• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫肝期抗原-1高度保守,含有强效的B细胞和T细胞决定簇。

Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants.

作者信息

Fidock D A, Gras-Masse H, Lepers J P, Brahimi K, Benmohamed L, Mellouk S, Guerin-Marchand C, Londono A, Raharimalala L, Meis J F

机构信息

Bio-Medical Parasitology Laboratory, Pasteur Institute, Paris, France.

出版信息

J Immunol. 1994 Jul 1;153(1):190-204.

PMID:7515922
Abstract

We have previously identified a Plasmodium falciparum liver stage-specific Ag (LSA-1) found to encode tandem 17 amino acid repeats harboring B cell determinants. Here we extend this study in terms of sequence analysis, protein localization, and immunologic properties. Analysis of the N- and C-terminal regions of LSA-1 from the T9/96 clone reveals high sequence conservation with LSA-1 from NF54. This 200-kDa protein is detected throughout liver schizogony and accumulates in the parasitophorous vacuole space. In our investigation of T and B cell responses to LSA-1, we have focused on both the area of the C-terminal, nonrepetitive "hinge" region and the conserved repetitive region and derived synthetic peptides. These were found to contain major B and T cell determinants. High prevalences and elevated Ab levels to LSA-1, directed primarily, although not exclusively, to the repetitive region, were detected in sera of individuals from one moderately high and two low transmission malaria-endemic areas (prevalences of 97%, 75, and 77%, respectively). In one of these low transmission areas, secretion of the cytokine IFN-gamma, known to inhibit malaria liver stages, and T cell proliferation were detected in PBMC of 22 to 48% and 6 to 20%, respectively, of individuals in response to separate LSA-1 peptides. These results complement the recent finding of conserved CTL epitopes in LSA-1 and support the assertion that immune responses to LS Ag are involved in protection against malaria pre-erythrocytic stages.

摘要

我们之前鉴定出一种恶性疟原虫肝期特异性抗原(LSA-1),发现其编码含有B细胞决定簇的串联17氨基酸重复序列。在此,我们在序列分析、蛋白质定位和免疫学特性方面扩展了这项研究。对T9/96克隆的LSA-1的N端和C端区域分析显示,其与NF54的LSA-1具有高度序列保守性。这种20 kDa的蛋白质在整个肝裂殖过程中都能检测到,并在寄生泡空间中积累。在我们对LSA-1的T细胞和B细胞反应的研究中,我们聚焦于C端非重复“铰链”区域和保守重复区域,并合成了肽段。发现这些肽段含有主要的B细胞和T细胞决定簇。在一个中度高传播和两个低传播疟疾流行地区的个体血清中,检测到针对LSA-1的高流行率和升高的抗体水平,主要(尽管并非唯一)针对重复区域(流行率分别为97%、75%和77%)。在其中一个低传播地区,已知可抑制疟疾肝期的细胞因子IFN-γ的分泌以及T细胞增殖,分别在22%至48%和6%至20%的个体外周血单个核细胞中检测到,这些个体对单独的LSA-1肽段有反应。这些结果补充了最近在LSA-1中发现的保守CTL表位,并支持了对肝期抗原的免疫反应参与预防疟疾红细胞前期的观点。

相似文献

1
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants.恶性疟原虫肝期抗原-1高度保守,含有强效的B细胞和T细胞决定簇。
J Immunol. 1994 Jul 1;153(1):190-204.
2
Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.在非洲儿童的非复杂性疟疾期间,恶性疟原虫肝期抗原-1肽特异性干扰素-γ反应未受到抑制。
Eur Cytokine Netw. 2001 Oct-Dec;12(4):647-53.
3
Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.在持续暴露于恶性疟原虫的个体中,针对疟疾热休克蛋白Pf72/Hsp70-1及其衍生肽段的抗体和反应性T细胞
J Immunol. 1992 Nov 15;149(10):3321-30.
4
Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.恶性疟原虫裂殖子表面蛋白(MSP)-1 C末端42-kDa结构域中人类识别的T细胞和B细胞表位的鉴定
J Immunol. 1995 Jun 1;154(11):6022-30.
5
Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.无佐剂脂肽免疫诱导小鼠和黑猩猩针对疟疾肝期抗原产生强效且持久的B细胞、辅助性T细胞和细胞毒性T淋巴细胞应答。
Eur J Immunol. 1997 May;27(5):1242-53. doi: 10.1002/eji.1830270528.
6
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.重组肝期抗原-1(LSA-1)与 AS01 或 AS02 联合使用是安全的,可引发高滴度抗体并诱导 IFN-γ/IL-2 CD4+T 细胞,但不能预防实验性疟原虫感染。
Vaccine. 2010 Jul 12;28(31):5135-44. doi: 10.1016/j.vaccine.2009.08.046. Epub 2009 Sep 6.
7
A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes.一种新型恶性疟原虫子孢子和肝期抗原(SALSA)可确定主要的B细胞、辅助性T细胞和细胞毒性T淋巴细胞表位。
J Immunol. 1996 Apr 15;156(8):2874-84.
8
Molecular analysis of the association of HLA-B53 and resistance to severe malaria.HLA - B53与严重疟疾抗性关联的分子分析
Nature. 1992 Dec 3;360(6403):434-9. doi: 10.1038/360434a0.
9
Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.恶性疟原虫血液期抗原Pf155/RESA诱导的人类调节性T细胞反应的特征
Behring Inst Mitt. 1994 Dec(95):97-105.
10
Immune response in mouse and malaria-exposed humans to peptides derived from Pf11-1, a highly repetitive megadalton protein of Plasmodium falciparum.小鼠及接触过疟疾的人类对源自Pf11-1(恶性疟原虫一种高度重复的兆道尔顿蛋白)的肽段的免疫反应。
Eur J Immunol. 1993 Jul;23(7):1574-81. doi: 10.1002/eji.1830230727.

引用本文的文献

1
Malaria-driven adaptation of MHC class I in wild bonobo populations.疟疾驱动野生倭黑猩猩 MHC Ⅰ类基因座的适应性进化。
Nat Commun. 2023 Feb 23;14(1):1033. doi: 10.1038/s41467-023-36623-9.
2
The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957.新型化学型 DDD01034957 的抗疟疗效和耐药机制。
Sci Rep. 2021 Jan 21;11(1):1888. doi: 10.1038/s41598-021-81343-z.
3
Progress in the Development of Subunit Vaccines against Malaria.抗疟疾亚单位疫苗的研发进展
Vaccines (Basel). 2020 Jul 10;8(3):373. doi: 10.3390/vaccines8030373.
4
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential.在全生物体疟原虫疫苗试验中使用的菌株在基因组结构、序列和免疫原性潜力方面存在差异。
Genome Med. 2020 Jan 8;12(1):6. doi: 10.1186/s13073-019-0708-9.
5
Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.疟原虫 LSA1 和 LSAP2 融合抗原的病毒载体的临床前开发和评估,以提高抗肝期疟疾的疗效。
Infect Immun. 2020 Jan 22;88(2). doi: 10.1128/IAI.00573-19.
6
High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.高密度肽阵列有助于鉴定自然感染疟疾个体中的线性免疫原性 B 细胞表位。
Mol Cell Proteomics. 2019 Apr;18(4):642-656. doi: 10.1074/mcp.RA118.000992. Epub 2019 Jan 10.
7
Repetitive sequences in malaria parasite proteins.疟原虫蛋白质中的重复序列。
FEMS Microbiol Rev. 2017 Nov 1;41(6):923-940. doi: 10.1093/femsre/fux046.
8
Immune Responses in Malaria.疟疾中的免疫反应
Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):a025577. doi: 10.1101/cshperspect.a025577.
9
An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.用于临床前红细胞前期疟疾疫苗开发的不断扩展的工具包:连接传统小鼠疟疾模型与人体试验
Future Microbiol. 2016 Dec;11(12):1563-1579. doi: 10.2217/fmb-2016-0077. Epub 2016 Nov 18.
10
Serological markers to measure recent changes in malaria at population level in Cambodia.用于衡量柬埔寨人群层面疟疾近期变化的血清学标志物。
Malar J. 2016 Nov 4;15(1):529. doi: 10.1186/s12936-016-1576-z.